Everolimus-eluting bioresorbable vascular scaffold implantation to treat saphenous vein graft disease, single-center initial experience.

about

Everolimus-eluting bioresorbable vascular scaffold implantation to treat saphenous vein graft disease, single-center initial experience.

Item

http://www.wikidata.org/entity/Q38629269

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Everolimus-eluting bioresorbab ...... gle-center initial experience.

@en

type

Item

label

Everolimus-eluting bioresorbab ...... gle-center initial experience.

@en

prefLabel

Everolimus-eluting bioresorbab ...... gle-center initial experience.

@en

P1476

Everolimus-eluting bioresorbab ...... ngle-center initial experience

@en

P2093

Guillaume Marquis-Gravel

http://www.w3.org/2001/XMLSchema#string

Hung Q Ly

http://www.w3.org/2001/XMLSchema#string

Jean-François Dorval

http://www.w3.org/2001/XMLSchema#string

Jean-François Tanguay

http://www.w3.org/2001/XMLSchema#string

Philippe L L'allier

http://www.w3.org/2001/XMLSchema#string

Robert Avram

http://www.w3.org/2001/XMLSchema#string

Serge Doucet

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study

Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).

Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry).

Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Clinical end points in coronary stent trials: a case for standardized definitions.

2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

Drug-eluting versus bare metal stent in treatment of patients with saphenous vein graft disease: A meta-analysis of randomized controlled trials.

P304

433-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIC.12425

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Quentin de Hemptinne

Fabien Picard

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28799238

http://www.w3.org/2001/XMLSchema#string